Cargando…

Analysis of B cell subsets in severe cutaneous adverse reaction

Detalles Bibliográficos
Autores principales:	Azukizawa, Hiroaki, Kato, Kenichi, Katayama, Ichiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128307/ http://dx.doi.org/10.1186/2045-7022-4-S3-P44

Ejemplares similares

Multiple drug hypersensitivity associated with severe cutaneous adverse reaction
por: Lin Choo, Karen Jui, et al.
Publicado: (2014)

Risk factors of mortality in severe cutaneous adverse reactions patients with pulmonary involvement
por: Hu, H, et al.
Publicado: (2012)

HLA-B*58:01 allele is strongly associated with allopurinol-induced severe cutaneous adverse reactions in a Thai population
por: Jantararoungtong, Thawinee, et al.
Publicado: (2014)

Patch testing in drug cutaneous adverse reactions: value of the extemporaneous preparations
por: Assier, Haudrey, et al.
Publicado: (2014)

Effects of immunomodulating therapies on mortality in patients with severe cutaneous adverse reactions in comparison with supportive care only: a systematic review
por: Zimmermann, Stefanie, et al.
Publicado: (2014)

An immunohistochemical study of the granulysin expression of 6 types of proven adverse cutaneous drug reaction
por: Weinborn, Marie, et al.
Publicado: (2014)

Drugs inducing T-cell mediated cutaneous adverse reactions and contact sensitizers evoke similar responses in THP-1 cells
por: Gonçalo, Margarida, et al.
Publicado: (2014)

A severe cutaneous reaction caused by acetaminophen in a pediatric patient
por: Schroeder, Jan, et al.
Publicado: (2014)

Cutaneous adverse reactions and anti-tumor effects of anti-CCR4 monoclonal antibody (mogamulizumab) on adult T-cell leukemia-lymphoma
por: Yonekura, Kentro, et al.
Publicado: (2015)

A prospective study of HLA*B-5801 genotyping in preventing allopurinol- induced severe cutaneous adverse reactions
por: Ko, Tai-Ming, et al.
Publicado: (2014)

Cutaneous adverse drug reactions induced by Oxcarbazepine
por: Hsiao, Yi-Hsin, et al.
Publicado: (2014)

B cell subsets phenotype in autoimmunity with immunodeficiency: analysis of a cohort of patients with APECED syndrome
por: Magnani, A, et al.
Publicado: (2011)

Incidence of anxiety and depression in a predominantly HIV-infected population with severe adverse drug reactions
por: Zitha, Eddy, et al.
Publicado: (2014)

Differential cytokine/chemokine profiles and reactivation of human herpes viruses in various forms of cutaneous adverse drug reactions. A comparative study in Taiwan
por: Chu, Chia-Yu, et al.
Publicado: (2014)

Adverse reactions to food in patients with mastocytosis
por: Pucino, Valentina, et al.
Publicado: (2011)

Epidermiology of adverse drug reactions (ADRs) in the elderly
por: Ju-Young, Kim, et al.
Publicado: (2014)

Non hepatitis jaundice - adverse reaction to rifampicin
por: Laza, Ruxandra, et al.
Publicado: (2014)

Basophil activation test is food adverse reactions
por: Pignatti, Patrizia, et al.
Publicado: (2011)

Treatments for Severe Cutaneous Adverse Reactions
por: Cho, Yung-Tsu, et al.
Publicado: (2017)

Genetics of Severe Cutaneous Adverse Reactions
por: Yang, Shang-Chen, et al.
Publicado: (2021)

Single-cell gene profiling analysis of human regulatory T cell subsets
por: Maiella, S, et al.
Publicado: (2010)

Cutaneous adverse events associated with long-term immunomodulating therapy in multiple sclerosis
por: Balak, Deepak MW, et al.
Publicado: (2011)

What are the psychological correlates of perceived adverse food reactions?
por: Mahmood, Saliha
Publicado: (2011)

Precision analysis of a whole blood T cell subset immunophenotyping assay
por: Apodaca, Minjun, et al.
Publicado: (2013)

Involvement of the activating receptor NKG2D in cutaneous hypersensitivity drug reactions
por: Bellón, Teresa, et al.
Publicado: (2014)

The adverse drug reactions to tumor necrosis factor alpha inhibitor
por: Park, Hye-Kyung, et al.
Publicado: (2014)

Mechanisms that limit proliferative potential of drug-specific LTT in drug-induced severe cutaneous adverse reaction patients
por: Valeyrie-Allanore, Laurence, et al.
Publicado: (2014)

Genetic markers of severe cutaneous adverse reactions
por: Jung, Jae-Woo, et al.
Publicado: (2018)

The assessment of severe cutaneous adverse drug reactions
por: Copaescu, Ana M, et al.
Publicado: (2022)

Chemokines in Severe Cutaneous Adverse Reactions (SCARs)
por: Miyagawa, Fumi, et al.
Publicado: (2021)

Cutaneous drug-reactions to nevirapine: study of risk factors in 268 HIV-infected patients
por: Badaoui, L, et al.
Publicado: (2014)

Expression and roles of glutamate (NMDA) receptors on T cell subsets
por: Orihara, Kanami, et al.
Publicado: (2010)

Efavirenz’ adverse reactions: a possible link between depression and gynecomastia
por: Diaconu, Ioan Alexandru, et al.
Publicado: (2014)

5613475 ADVERSE REACTIONS TO RBC TRANSFUSION: A SINGLE THALASSEMIA AND SICKLE CELL DISEASE DEPARTMENT’S EXPERIENCE
por: Xydaki, A.X., et al.
Publicado: (2023)

Lyoplate-based multiparameter flow cytometry for the analysis of T cell subsets in human immuno-monitoring studies
por: Villanova, Federica, et al.
Publicado: (2011)

HLA-DR expression on monocytes and the T-cell subset in septic patients
por: Menestrina, N, et al.
Publicado: (2005)

P25 - Hypersensitivity/adverse reactions to antituberculosis drugs – a case report
por: Barrosa Maia, Estefânia, et al.
Publicado: (2014)

Subset analysis of the safety and efficacy of nivolumab in elderly patients with metastatic melanoma
por: Freeman, Morganna, et al.
Publicado: (2015)

Type II NKT cells differentially regulate CD4 T cell subsets
por: Robertson, Faith C, et al.
Publicado: (2014)

Usefulness of patch tests in drug adverse reaction induced by tetrazepam and anti-inflammatory drugs
por: Assier, Haudrey, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_aoa6mpeh58vu3deqokka1gdc6t